Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)
Vietnam · Delayed Price · Currency is VND 61,900
-500 (-0.80%)
At close: Jun 12, 2026
HNX:DP3 Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,330,846 | 1,135,196 | 1,253,446 | 1,408,246 | 808,400 | 971,800 | |
Market Cap Growth | 14.63% | -9.43% | -10.99% | 74.20% | -16.81% | 30.18% |
Enterprise Value | 866,014 | 736,739 | 929,277 | 1,160,824 | 640,122 | 859,776 |
Last Close Price | 61900.00 | 49452.93 | 51962.14 | 55963.72 | 29640.19 | 33788.29 |
PE Ratio | 8.09 | 7.39 | 10.34 | 11.24 | 7.43 | 10.31 |
PS Ratio | 2.77 | 2.59 | 3.00 | 3.44 | 1.67 | 2.55 |
PB Ratio | 2.06 | 1.87 | 2.42 | 3.01 | 1.94 | 2.65 |
P/TBV Ratio | 2.13 | 1.93 | 2.51 | 3.14 | 1.97 | 2.70 |
P/FCF Ratio | - | 4.69 | 13.86 | 9.60 | 9.61 | 37.58 |
P/OCF Ratio | 4.88 | 4.69 | 13.64 | 9.20 | 8.15 | 36.94 |
EV/Sales Ratio | 1.80 | 1.68 | 2.23 | 2.83 | 1.32 | 2.26 |
EV/EBITDA Ratio | 4.43 | 4.05 | 6.21 | 7.69 | - | - |
EV/EBIT Ratio | 4.72 | 4.32 | 6.80 | 8.48 | 5.01 | 7.67 |
EV/FCF Ratio | - | 3.04 | 10.27 | 7.91 | 7.61 | 33.24 |
Debt / Equity Ratio | 0.05 | 0.06 | - | 0.02 | 0.01 | 0.01 |
Debt / EBITDA Ratio | 0.17 | 0.19 | - | 0.05 | - | - |
Debt / FCF Ratio | 0.12 | 0.14 | - | 0.05 | 0.06 | 0.14 |
Net Debt / Equity Ratio | -0.72 | -0.73 | -0.66 | -0.64 | -0.48 | -0.43 |
Net Debt / EBITDA Ratio | -2.38 | -2.42 | -2.28 | -1.98 | - | - |
Net Debt / FCF Ratio | -1.70 | -1.82 | -3.78 | -2.03 | -2.39 | -6.12 |
Asset Turnover | 0.67 | 0.64 | 0.71 | 0.76 | 1.02 | 0.86 |
Inventory Turnover | 2.72 | 2.99 | 2.94 | 2.10 | 2.17 | 1.90 |
Quick Ratio | 3.67 | 3.55 | 4.29 | 3.25 | 2.60 | 2.31 |
Current Ratio | 4.18 | 3.96 | 4.88 | 3.79 | 3.43 | 3.22 |
Return on Equity (ROE) | 27.69% | 27.26% | 24.55% | 28.28% | 27.77% | 26.46% |
Return on Assets (ROA) | 15.89% | 15.62% | 14.50% | 15.87% | 16.76% | 15.81% |
Return on Invested Capital (ROIC) | 84.24% | 71.80% | 62.83% | 56.58% | 48.04% | 44.85% |
Return on Capital Employed (ROCE) | 28.40% | 28.00% | 26.30% | 29.20% | 30.60% | 30.60% |
Earnings Yield | 12.36% | 13.53% | 9.67% | 8.89% | 13.46% | 9.70% |
FCF Yield | - | 21.32% | 7.22% | 10.42% | 10.41% | 2.66% |
Dividend Yield | 6.46% | 8.09% | - | 5.36% | - | 7.10% |
Payout Ratio | 37.81% | 40.50% | 53.22% | 54.84% | 45.84% | 70.55% |
Buyback Yield / Dilution | -0.01% | - | - | 5.00% | -5.27% | 0.00% |
Total Shareholder Return | 6.41% | 8.09% | - | 10.36% | -5.27% | 7.11% |